Published in J Orthop Res on May 09, 2014
Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr (2004) 5.88
Cross-linking in collagen and elastin. Annu Rev Biochem (1984) 3.51
From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr (2008) 3.04
Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int (2010) 2.69
Lysine hydroxylation and cross-linking of collagen. Methods Mol Biol (2008) 1.58
Lysine post-translational modifications of collagen. Essays Biochem (2012) 1.49
Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci U S A (1999) 1.39
Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int (1994) 1.20
Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J Bone Miner Res (2004) 1.13
Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells. J Bone Miner Res (2004) 1.12
1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 . Science (1973) 1.10
Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells. Bone (1991) 1.06
The post-translational chemistry and molecular packing of mineralizing tendon collagens. Connect Tissue Res (1993) 1.06
Lysyl hydroxylase 3-mediated glucosylation in type I collagen: molecular loci and biological significance. J Biol Chem (2012) 1.03
Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. Biochem J (1992) 0.99
Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Miner Res (2000) 0.98
Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res (1998) 0.97
A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif Tissue Int (2002) 0.94
The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis. Calcif Tissue Int (1999) 0.94
Biological activity of 1alpha-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3. Proc Natl Acad Sci U S A (1973) 0.92
Effect of 1alpha-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model. Endocrinology (1996) 0.90
Cementum-forming cells are phenotypically distinct from bone-forming cells. J Bone Miner Res (2000) 0.88
Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Bone (2009) 0.85
Regional alterations of type I collagen in rat tibia induced by skeletal unloading. J Bone Miner Res (2002) 0.84
Association between collagen cross-links and trabecular microarchitecture properties of human vertebral bone. Bone (2009) 0.84
1,25(OH)2D3 regulates collagen quality in an osteoblastic cell culture system. Biochem Biophys Res Commun (2008) 0.84
1,25-Dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. Endocrinology (1989) 0.83
Pharmacokinetics of active vitamins D3, 1 alpha-hydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in patients on chronic hemodialysis. Clin Nephrol (1991) 0.81
Alfacalcidol restores cancellous bone in ovariectomized rats. J Musculoskelet Neuronal Interact (2003) 0.80
Role of vitamin D, its metabolites, and analogs in the management of osteoporosis. Rheum Dis Clin North Am (1994) 0.79
A new look at the most successful prodrugs for active vitamin D (D hormone): alfacalcidol and doxercalciferol. Molecules (2009) 0.79
Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol. Rheumatol Int (2007) 0.78
1,25-Dihydroxyvitamin D3 inhibition of col1a1 promoter expression in calvariae from neonatal transgenic mice. Biochim Biophys Acta (1998) 0.78
Occlusal hypofunction induces atrophic changes in rat gingiva. Angle Orthod (2008) 0.77
Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell (2009) 14.40
PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest (2004) 5.29
Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell (2007) 4.71
Crm1 is a mitotic effector of Ran-GTP in somatic cells. Nat Cell Biol (2005) 2.56
Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest (2004) 2.16
BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development (2008) 1.86
Application of crosslinkers to dentin collagen enhances the ultimate tensile strength. J Biomed Mater Res B Appl Biomater (2007) 1.76
Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J Cereb Blood Flow Metab (2006) 1.75
SUSP1 antagonizes formation of highly SUMO2/3-conjugated species. J Cell Biol (2006) 1.67
Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J Biol Chem (2004) 1.65
Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS One (2007) 1.56
Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res (2010) 1.54
Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res (2008) 1.54
Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology (2010) 1.48
Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. J Biol Chem (2005) 1.47
Lysyl oxidase binds transforming growth factor-beta and regulates its signaling via amine oxidase activity. J Biol Chem (2008) 1.47
Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol (2002) 1.30
Pulp revascularization of immature dog teeth with apical periodontitis. J Endod (2007) 1.30
GSK-3beta controls osteogenesis through regulating Runx2 activity. PLoS One (2007) 1.29
Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am J Physiol Gastrointest Liver Physiol (2013) 1.28
Effects of formalin fixation and collagen cross-linking on T2 and magnetization transfer in bovine nasal cartilage. Magn Reson Med (2007) 1.27
Biglycan modulates osteoblast differentiation and matrix mineralization. J Bone Miner Res (2005) 1.26
Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates. Hepatology (2010) 1.22
PIASgamma is required for faithful chromosome segregation in human cells. PLoS One (2006) 1.21
Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J Bone Miner Res (2004) 1.13
Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells. J Bone Miner Res (2004) 1.12
PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity. J Cell Biol (2010) 1.10
Lysyl hydroxylase 3-mediated glucosylation in type I collagen: molecular loci and biological significance. J Biol Chem (2012) 1.03
Carminerin contributes to chondrocyte calcification during endochondral ossification. Nat Med (2006) 1.03
Nephrocan, a novel member of the small leucine-rich repeat protein family, is an inhibitor of transforming growth factor-beta signaling. J Biol Chem (2006) 1.01
Lysyl hydroxylase 3 glucosylates galactosylhydroxylysine residues in type I collagen in osteoblast culture. J Biol Chem (2011) 1.01
Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition. Mol Biol Cell (2008) 0.99
Decorin modulates matrix mineralization in vitro. Biochem Biophys Res Commun (2003) 0.98
Decorin modulates collagen matrix assembly and mineralization. Matrix Biol (2008) 0.98
Ascorbic acid-independent synthesis of collagen in mice. Am J Physiol Endocrinol Metab (2005) 0.97
Novel association of APC with intermediate filaments identified using a new versatile APC antibody. BMC Cell Biol (2009) 0.97
PIASy mediates SUMO-2/3 conjugation of poly(ADP-ribose) polymerase 1 (PARP1) on mitotic chromosomes. J Biol Chem (2010) 0.95
Titanium surface topography affects collagen biosynthesis of adherent cells. Bone (2011) 0.94
Human enamel phenotype associated with amelogenesis imperfecta and a kallikrein-4 (g.2142G>A) proteinase mutation. Eur J Oral Sci (2006) 0.94
Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation. Adv Exp Med Biol (2006) 0.94
SRC-1 is necessary for skeletal responses to sex hormones in both males and females. J Bone Miner Res (2004) 0.94
SUMOylation of the C-terminal domain of DNA topoisomerase IIα regulates the centromeric localization of Claspin. Cell Cycle (2015) 0.94
TRAF5 functions in both RANKL- and TNFalpha-induced osteoclastogenesis. J Bone Miner Res (2003) 0.92
Immunohistochemical localization of matrixmetalloproteinase-2 in human coronal dentin. Arch Oral Biol (2007) 0.91
Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation. J Biol Chem (2010) 0.91
Molecular mechanism of the vitamin D antagonistic actions of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone depends on the primary structure of the carboxyl-terminal region of the vitamin d receptor. Mol Endocrinol (2005) 0.91
Chitosan monomer promotes tissue regeneration on dental pulp wounds. J Biomed Mater Res A (2006) 0.90
Identification and developmental expression of Xenopus laevis SUMO proteases. PLoS One (2009) 0.90
Positive effect of alendronate on subchondral bone healing and subsequent cartilage repair in a rabbit osteochondral defect model. Am J Sports Med (2009) 0.90
S100A4: a novel negative regulator of mineralization and osteoblast differentiation. J Bone Miner Res (2003) 0.90
Tissue engineering strategies for immature teeth with apical periodontitis. J Endod (2011) 0.89
Lysine hydroxylation of collagen in a fibroblast cell culture system. Biochem Biophys Res Commun (2003) 0.88
Immunohistological characterization of newly formed tissues after regenerative procedure in immature dog teeth. J Endod (2011) 0.87
Expression of lysyl oxidase isoforms in MC3T3-E1 osteoblastic cells. Biochem Biophys Res Commun (2005) 0.87
Timing for composite resin placement on mineral trioxide aggregate. J Endod (2013) 0.86
Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma. J Clin Invest (2015) 0.86
Effect of orifice plugs on periapical inflammation in dogs. J Endod (2006) 0.85
Collagen dysregulation in the dermis of the Sagg/+ mouse: a loose skin model. J Invest Dermatol (2006) 0.85
Post-translational modifications of collagen upon BMP-induced osteoblast differentiation. Biochem Biophys Res Commun (2007) 0.85
GLUT1 is highly expressed in cementoblasts but not in osteoblasts. Connect Tissue Res (2005) 0.85
Three-dimensional analysis of the temporomandibular joint and fossa-condyle relationship. Orthodontics (Chic.) (2011) 0.85
Removal of dentin matrix proteoglycans by trypsin digestion and its effect on dentin bonding. J Biomed Mater Res B Appl Biomater (2008) 0.84
Effects of fish collagen peptides on collagen post-translational modifications and mineralization in an osteoblastic cell culture system. Dent Mater J (2013) 0.84
Regional alterations of type I collagen in rat tibia induced by skeletal unloading. J Bone Miner Res (2002) 0.84
Identification and characterization of neural crest-derived cells in adult periodontal ligament of mice. Arch Oral Biol (2012) 0.84
Three-dimensional analysis of the pharyngeal airway morphology in growing Japanese girls with and without cleft lip and palate. Am J Orthod Dentofacial Orthop (2012) 0.83
Chitosan and fish collagen as biomaterials for regenerative medicine. Adv Food Nutr Res (2012) 0.83
Three-dimensional computer-generated head model reconstructed from cephalograms, facial photographs, and dental cast models. Am J Orthod Dentofacial Orthop (2005) 0.83
Effects of timing of low-intensity pulsed ultrasound on distraction osteogenesis. J Orthop Res (2004) 0.83
Curative effect of combined treatment with alendronate and 1 alpha-hydroxyvitamin D3 on bone loss by ovariectomy in aged rats. Jpn J Pharmacol (2002) 0.82
Role of the tumor necrosis factor-alpha, cyclooxygenase-2, prostaglandin E2, and effect of low-intensity pulsed ultrasound in an in vitro herniated disc resorption model. J Orthop Res (2008) 0.82
Temporal changes in collagen cross-links in spontaneous articular cartilage repair. Cartilage (2012) 0.82
Osteoclastogenesis-related antigen, a novel molecule on mouse stromal cells, regulates osteoclastogenesis. J Bone Miner Res (2003) 0.82
Unusual fragmentation pathways in collagen glycopeptides. J Am Soc Mass Spectrom (2013) 0.81
Changes in matrix phosphorylation during bovine dentin development. Eur J Oral Sci (2007) 0.80
Early gene expression analyzed by cDNA microarray and RT-PCR in osteoblasts cultured with water-soluble and low molecular chitooligosaccharide. Biomaterials (2004) 0.80
Podocan-like protein: a novel small leucine-rich repeat matrix protein in bone. Biochem Biophys Res Commun (2011) 0.79
A novel mutation in the lysyl hydroxylase 1 gene causes decreased lysyl hydroxylase activity in an Ehlers-Danlos VIA patient. J Invest Dermatol (2005) 0.79
The SUMO ligase PIAS1 regulates UV-induced apoptosis by recruiting Daxx to SUMOylated foci. J Cell Sci (2012) 0.79
Retracted CDP/cut is an osteoblastic coactivator of the vitamin D receptor (VDR). J Bone Miner Res (2010) 0.78
In vitro evaluation of low-intensity pulsed ultrasound in herniated disc resorption. Biomaterials (2005) 0.78
Quantitative determination of binding of ISWI to nucleosomes and DNA shows allosteric regulation of DNA binding by nucleotides. Biochemistry (2014) 0.77
Zinc as an essential trace element in the acceleration of matrix vesicles-mediated mineral deposition. Microsc Res Tech (2011) 0.77
Influence of tooth age and etching time on the microtensile bond strengths of adhesive systems to dentin. J Adhes Dent (2012) 0.77
Distribution and relative activity of matrix metalloproteinase-2 in human coronal dentin. Int J Oral Sci (2011) 0.76
Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment. Anticancer Res (2009) 0.76
Differential gene expression of collagen-binding small leucine-rich proteoglycans and lysyl hydroxylases, during mineralization by MC3T3-E1 cells cultured on titanium implant material. Eur J Oral Sci (2005) 0.76
Biochemical characterization of collagen in alveolar mucosa and attached gingiva of pig. Connect Tissue Res (2007) 0.76
Alendronate inhibits bone resorption at the bone-screw interface. Clin Orthop Relat Res (2005) 0.76
A novel proteolytic processing of prolysyl oxidase. Connect Tissue Res (2011) 0.76
Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period. J Bone Miner Metab (2009) 0.76
Synthesis of novel C-2 substituted vitamin D derivatives having ringed side chains and their biological evaluation on bone. J Steroid Biochem Mol Biol (2013) 0.76
Early gene expression analyzed by cDNA microarray and real-time PCR in osteoblasts cultured with chitosan monomer. J Biomed Mater Res A (2007) 0.76
Characterization of mandibular bones in senile osteoporotic mice. Connect Tissue Res (2008) 0.76